<p>The Myelofibrosis Etiology and Transplant Outcomes study is a collaboration between the <a href="https://www.cancer.gov/">National Cancer Institute</a> and the Center for International Blood and Marrow Transplant Research (<a href="https://www.cibmtr.org/Pages/index.aspx">CIBMTR</a>). The study aims to identify genomic factors affecting myelofibrosis pathogenesis and prognosis.</p>

Myelofibrosis Etiology and Transplant Outcomes

Primary Myelofibrosis study with AMPLICON, SNP Genotypes (Array) + 1 more data on dbGaP (548 participants)